1. Introduction {#sec1-ijerph-16-03524}
===============

Depression is a common brain disorder worldwide and is characterized by key symptoms of low and depressed mood, loss of interest and pleasure, fatigue, and reduced energy for at least 2 weeks \[[@B1-ijerph-16-03524]\]. Depression can be a solitary disorder with an idiopathic cause, or it can be coexisting with another disease, which increases the complexity and care burden of the depression itself. The prevalence rate of coexisting depression in patients with various neurological disorders, such as stroke, multiple sclerosis, Parkinson's disease, or epilepsy, is 20--50% \[[@B2-ijerph-16-03524]\]. In addition, patients with depression usually experience low self-confidence, guilt feeling with self-blame, and suicidal ideation. Depression is thus known as the main psychiatric disorder associated with suicidal behavior or suicide attempt (SA) \[[@B3-ijerph-16-03524],[@B4-ijerph-16-03524]\]. However, depression is usually underdiagnosed and undertreated even in developed Western countries \[[@B5-ijerph-16-03524],[@B6-ijerph-16-03524]\]. Moreover, one of five adults has considered suicide in United Kingdom and one in 15 has attempted suicide \[[@B7-ijerph-16-03524]\]. Thus, the majority of patients at a high risk of suicide will not die by suicide. Instead of the low predictive value and efficiency by finding the ones with suicide ideation, identifying the ones who at a high risk for attempting suicide and who might die by suicide should be the priority for patient safety and suicide prevention among individuals with depression \[[@B7-ijerph-16-03524]\].

Even in the 21st century, head injury remains one of the leading causes of death worldwide, irrespective of Western or Asian countries \[[@B8-ijerph-16-03524],[@B9-ijerph-16-03524]\]. In a study including 48,792 Taiwanese patients admitted with moderate or severe head injury, 4935 patients died, and the standardized in-hospital mortality rate for head injury was 10.7 deaths per 100,000 person-years in Taiwan \[[@B10-ijerph-16-03524]\]. However, head injury may result in various degrees of paralysis, consciousness impairment, and cognitive problems other than death. Patients surviving an initial admission for head injury often experience long-term or even life-long emotional and mental consequences \[[@B11-ijerph-16-03524],[@B12-ijerph-16-03524],[@B13-ijerph-16-03524]\], which can probably increase the severity of depression and the risk of SA \[[@B14-ijerph-16-03524],[@B15-ijerph-16-03524]\]. However, it remains unclear to what extent the risk of SA is increased in patients with depression following a head injury. We believe that a more thorough understanding of the risk and risk factors for suicidal behavior in patients with depression plays a key role in building an effective strategy for suicide prevention.

Taiwan is located in East Asia and has similar mores to those of China and most of Southeast Asian societies \[[@B16-ijerph-16-03524]\]. The Taiwanese government has run an established nationwide health care system for 2 decades \[[@B17-ijerph-16-03524]\]. This study used the Taiwan National Health Insurance Research Database (NHIRD) to determine whether the risk of SA was increased in patients with depression admitted for head injury. Because of the differences in cultural, ethnic, and socioeconomic backgrounds between Taiwanese and Western societies \[[@B16-ijerph-16-03524],[@B18-ijerph-16-03524]\] our data regarding the risk of SA in Taiwanese patients might not be applicable to Western countries. However, these data could be beneficial both for the Taiwanese clinicians and government and for other Asian countries.

2. Methods {#sec2-ijerph-16-03524}
==========

2.1. Data Source {#sec2dot1-ijerph-16-03524}
----------------

In 1995, Taiwan government implemented a nationwide database (NHIRD), which includes the medical records of all beneficiaries of the single-payer health care system in Taiwan. Medical records include the history of outpatient visits, hospitalizations, prescriptions of medication, and other medical services. As of today, more than 99% of residents are enrolled in the database \[[@B17-ijerph-16-03524]\]. To ensure the high validity of this study, we used hospitalization files from the NHIRD. All study participants were patients with a hospitalization record. The identification number of each study participant was recoded before the database was released by the government. Diagnoses were made according to the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) coding system. The Research Ethics Committee of the China Medical University and Hospital in Taiwan approved the study (CMUH104-REC2-115-CR4).

2.2. Study Population {#sec2dot2-ijerph-16-03524}
---------------------

To clarify the association between patients with depression admitted for head injury and the risk of SA and suicidal drug overdose (SDO), we included patients aged 20 or more and defined four cohorts as follows: patients with depression (ICD-9 CM: 296.2, 296.3, 296.82, 300.4, and 311) constituted the total depression cohort; patients with depression and admitted for head injury (ICD-9 CM: 850--854 and 959.01) represented the DHI group; and patients with depression but without head injury were part of the DWI group. Patients without depression or head injury between 2000 and 2010 were selected as the comparison cohort. The date a patient received head injury or depression diagnosis was defined as the index date in the DHI and DWI cohorts. The comparison cohort was frequency-matched by sex, age, and index year.

2.3. Outcome Measurement {#sec2dot3-ijerph-16-03524}
------------------------

The primary outcome in this study was the occurrence of SA (ICD-9-CM: E950--E959). To further understand the risk of SA and the safety of long-term prescription in patients with depression, both the SDO and SA in these cohorts were analyzed. SDO was defined as hospitalization with the ICD-9-CM codes 960--979 but without E codes. We excluded patients younger than 20 years and those who experienced SA or SDO before the index date. The covariates included a history of schizophrenia (ICD-9 CM: 295), alcohol-related illness (ICD-9 CM: 291, 303, 305.00, 305.01, 305.02, 305.03, 571.0, 571.1, 571.3, 790.3, and V11.3), anxiety (ICD-9 CM: 300.00), mental disorders (ICD-9 CM: 290--319), insomnia (ICD-9 CM: 307.4 and 780.5), diabetes mellitus (ICD-9 CM: 250), hypertension (ICD-9 CM: 401--405), hyperlipidemia (ICD-9 CM: 272), chronic obstructive pulmonary disease (COPD) (ICD-9 CM: 491, 492 and 496), coronary artery disease (CAD) (ICD-9 CM: 410--414), stroke (ICD-9 CM: 430---38), and cirrhosis (ICD-9 CM: 571, 572), which were all defined by at least one hospitalization record before the index date. The follow-up period for the study participants began at the index date and lasted until the date of SA or SDO, death, withdrawal from the NHIRD, or December 31, 2011, whichever came first.

2.4. Statistical Analysis {#sec2dot4-ijerph-16-03524}
-------------------------

In this study, we expressed the demographic factors and mean age by number (%) and mean (standard deviation (SD)) for the categorical and continuous variables, respectively. The differences in variables among the four cohorts were tested using the chi-square test for categorical variables and analysis of variance for continuous variables. The incidence rates of SA and SDO were calculated by dividing the SA or SDO events by the person-years (every 10,000 person-years). The Kaplan--Meier method was applied to demonstrate the cumulative incidence curve of development of SA and SDO in the DHI, DWI, and comparison cohorts, and the differences between the cumulative incidence curves were established using the log-rank test. The risks of SA and SDO in the total depression, DHI, DWI, and comparison cohorts were evaluated using crude and adjusted Cox proportional hazard models and presented as hazard ratios (HRs), adjusted HRs (aHRs), and 95% confidence intervals (CIs). The statistical analyses were conducted with type I error α = 0.05 using a statistical software package, SAS, version 9.4 (SAS Institute, Inc, Cary, NC, USA).

3. Results {#sec3-ijerph-16-03524}
==========

In this study, we identified the following four cohorts: total depression (*n* = 669,244), DWI (*n* = 647,375), DHI (*n* = 21,869), and comparison (*n* = 1,338,487) cohorts. After frequency matching by sex, age, and index year, no significant differences were observed among the four groups (*p* = 0.99). Significant differences were noted among the four cohorts in the monthly income, urbanization level, occupation, and comorbidities (*p* \< 0.001). Of the participants constituting the overall study cohorts, 60.1% were men, and 39.9% were women. The mean (SD) age was 46.8 (19.3) years in the total depression (DHI + DWI) cohort and 46.6 (19.3) years in the comparison cohorts ([Table 1](#ijerph-16-03524-t001){ref-type="table"}).

[Figure 1](#ijerph-16-03524-f001){ref-type="fig"} presents the cumulative incidence curves of SA and SDO in the DHI, DWI, and comparison cohorts. The results revealed significant differences in the cumulative incidences of SA between the DHI, DWI, and comparison cohorts, with a *p* value for the log-rank test of \<0.001 ([Figure 1](#ijerph-16-03524-f001){ref-type="fig"}A). Moreover, the results indicated significant differences in the cumulative incidences of SDO between the DWI, DHI, and comparison cohorts, with a *p* value for the log-rank test of \<0.001 ([Figure 1](#ijerph-16-03524-f001){ref-type="fig"}B).

[Table 2](#ijerph-16-03524-t002){ref-type="table"} exhibits the event numbers, incidences, HRs, and 95% CIs for distinct risk factors associated with SA. The incidences of SA in the comparison, total depression, DWI, and DHI cohorts were 1.16, 5.50, 3.76, and 63.3 per 10,000 person-years, respectively. Compared with each comparison group, patients in the DHI cohort (aHR = 37.4, 95% CI = 32.9--42.4) and aged less than 50 (aHR = 1.45, 95% CI = 1.30--1.62) had specifically significantly higher risks of SA than others. Patients with monthly income of less than New Taiwan Dollar (NTD) 15,000 (aHR = 1.66, 95% CI = 1.44--1.90), with a monthly income of NTD 15,000--19,999 (aHR = 1.56, 95% CI = 1.38--1.76), living in urbanization level two, three, and four areas (aHR = 1.33, 1.51, 1.64; 95% CI = 1.18--1.50, 1.32--1.72, 1.46--1.85), with a laborer occupation (aHR = 1.24, 95% CI = 1.13--1.36), with other occupations (aHR = 1.29, 95% CI = 1.13--1.36), and with comorbidities of schizophrenia (aHR = 3.28, 95% CI = 2.61--4.11), alcohol-related illness (aHR = 3.80, 95% CI = 3.16--4.56), anxiety (aHR = 2.32, 95% CI = 1.82--2.96), mental disorder (aHR = 0.71, 95% CI = 0.58--0.87), insomnia (aHR = 2.37, 95% CI = 1.96--2.85), diabetes (aHR = 1.31, 95% CI = 1.13--1.51), hyperlipidemia (aHR = 1.36, 95% CI = 1.15--1.60), COPD (aHR = 1.22, 95% CI = 1.03--1.45), and cirrhosis (aHR = 1.26, 95% CI = 1.07--1.47) had significantly higher risks of SA after adjustment for demographic factors and comorbidities ([Table 2](#ijerph-16-03524-t002){ref-type="table"}).

[Table 3](#ijerph-16-03524-t003){ref-type="table"} presents the analysis results of SA risk stratified by sex, age, monthly income, urbanization level, occupation, comorbidities, and compared with the comparison cohorts. Patients aged less than 50, aged 50--64, aged ≥65 years, of female sex, and male sex all had significantly higher risks of SA. When stratified with monthly income, urbanization level, and occupation, patients with monthly income of less than NTD 15,000, monthly income of NTD 15,000--19,999, monthly income of ≥NTD 20,000, living in urbanization level one to four areas, working as office workers, laborers, and other occupations all had significantly higher risks of SA in the total depression, DWI, and DHI cohorts. Both the patients with any one of the comorbidities and without had significantly higher risks of SA in the total depression, DWI, and DHI cohorts. When specifically considering the enhancing effects of admission for head injury and depression on the DHI cohort, patients aged \<50 years, of female sex, and without other comorbidity had extremely higher risks of SA than others ([Table 3](#ijerph-16-03524-t003){ref-type="table"}).

Because we determined that admission for head injury had a significantly enhancing effect on SA in patients with depression, we further compared the DHI cohort to the DWI cohort, and the results are presented in [Table 4](#ijerph-16-03524-t004){ref-type="table"}. We noted that patients in the DHI cohort (aHR = 14.8, 95% CI = 13.2--16.7), aged \<50 years (aHR = 18.8, 95% CI = 16.4--21.5), of female sex (aHR = 21.7, 95% CI = 18.4--25.7), and without any comorbidity (aHR = 22.7, 95% CI = 19.6--26.4) had specifically significantly higher risks of SA. When considered the monthly income, urbanization, and occupation of patients, the ones with monthly income of less than NTD 15000, monthly income of NTD 15000-19999, and monthly income of ≥NTD 20000; the ones living in urbanization level one areas, level two areas, level three areas, and level four areas; who are office workers, laborers, and in other occupations all had significantly higher risks of SA ([Table 4](#ijerph-16-03524-t004){ref-type="table"}).

The total depression, DWI, and DHI cohorts appeared to exhibit positive associations with SDO after adjustment for age, monthly income, urbanization level, and comorbidities. The incidences of SDO in the comparison, total depression, DWI, and DHI cohorts were 2.64, 9.34, 6.97, and 88.6 per 10,000 person-years, respectively. Compared with the comparison cohort, patients had significantly higher risks for SDO in the total depression (aHR = 2.71, 95% CI = 2.55--2.88), DWI (aHR = 2.20, 95% CI = 2.06--2.34), and DHI (aHR = 17.1, 95% CI = 15.5--18.8) cohorts. When compared with the DWI cohort, the DHI cohort had a significantly higher risk of SDO (aHR = 9.04, 95% CI = 8.22--9.94) ([Table 5](#ijerph-16-03524-t005){ref-type="table"}). In addition, we noted that the DHI cohort exhibited higher risks of SDO when combined with poisoning by medicinal substances (aHR = 14.4, 95% CI = 11.4--18.3), tranquilizers (aHR = 16.3, 95% CI = 13.3--19.9), and others (aHR = 6.68, 95% CI = 5.91--7.55) than did the DWI cohort.

4. Discussion {#sec4-ijerph-16-03524}
=============

In this study including participants aged ≥20 years and with a 12-year follow-up period, we observed that 3.27% (21,869 out of 669,244) of patients with depression were admitted for head injury. After admission for head injury, patients had a high (37.4 times) risk of SA compared with the patients without head injury who had a moderately increased (2.76 times) risk of SA. Moreover, patients with head injury had a following aHR of SDO as high as 17.1 compared to those in the comparison group; the DHI cohort had higher aHRs of 9.04, 14.4, and 16.3 for all SDO, poisoning by medicinal substances, and poisoning by tranquilizers, respectively, compared to the DWI cohort. Our observation in this study revealed evident proportional increases in the risks of SA and SDO in the patients with depression and head injury. This implied that medical substances and tranquilizers taken from the medical care system could be dangerously abused for SA (by taking a high dose of medications at one time) by patients with depression and head injury. A long-term prescription containing large amounts of medications should be carefully attributed for patients with coexisting depression and head injury in the future.

Apart from the known standardized hospitalization death rate of 10.7 deaths per 100,000 person-years in Taiwanese patients with traumatic head injury only \[[@B10-ijerph-16-03524]\], this study revealed other risks in patients with depression and head injury, namely SA and SDO risks. The incidences of SA and SDO were 63.3 and 88.6 per 10,000 person-years, respectively, in patients with depression surviving from a head injury. Furthermore, our data in this study implied that their suicide risk could cumulatively increase in a decade or more. Therefore, we suggest that admission for head injury should be considered a serious disorder when interacting with patients with depression and highly dangerous for suicidal behaviors in these patients. In the literature, most previous studies have been designed to evaluate the suicidal risk mediated by the development of depression in patients surviving head injury \[[@B19-ijerph-16-03524],[@B20-ijerph-16-03524],[@B21-ijerph-16-03524]\]. Increasing awareness of depression in the population with head injury would help identify at-risk individuals, particularly because of the current general belief that depression is a common sequela after traumatic brain injury. To the best of our knowledge, this study provided the first nationwide population-based evidence of the risks of suicide attempt and drug overdose following a head injury in patients with depression. We documented the overwhelming enhancement of SA and SDO deriving from the admission for head injury in patients with depression for the first time.

According to Taiwan NHI guidelines, if a patient experiences a head injury with clear consciousness and does not have any intracranial hemorrhage or brain contusion based on brain images, the patient's head injury is classified as mild and as one to be treated in an outpatient service. Therefore, patients admitted for head injuries in this study were classified as moderate or severe with promising brain injuries or insults. The effects of depression and admission for head injury on suicidal behaviors and how they interact to increase the risks of SA and SDO require clarification. From the aspect of neuro-psychological factors of an individual with head injury, effects of various factors such as chronic cognitive and physical fatigue and associated psychiatric, sleep, or psychosocial sequelae are usually developed in patients \[[@B21-ijerph-16-03524],[@B22-ijerph-16-03524],[@B23-ijerph-16-03524]\]. Post-traumatic amnesia, poor attention, impaired processing speed, and anxiety were noted and led to a pre- and post-injury gap in patients with pre-existing depression. Patients have difficulties re-engaging in the desired living activities and are more likely to experience anxiety, which in turn may contribute to suicidal behaviors. In addition, biological evidence has demonstrated that head injury with brain insult could increase the neuro-inflammation pathologies over the blood--brain barrier, glutamate regulation, microglia activation, and even autoimmune response \[[@B24-ijerph-16-03524],[@B25-ijerph-16-03524]\]. The elevation of the levels of pro-inflammatory cytokines has been documented in patients with major depressive disorder and bipolar disorder with the induction of depressive symptomatology. All of those conditions facilitate the further development of depression and other mental disorders, which are associated with suicidality.

SDO is a nonviolent suicide method with a generally lower mortality rate than suicide by violent means. Because of the restricted access to firearms in most Asian countries, Asian patients may find it easier to attempt suicide through the nonviolent method of self-poisoning \[[@B26-ijerph-16-03524],[@B27-ijerph-16-03524]\]. This study reminds us that self-poisoning with medical substances or tranquilizers is the most accessible method for attempting suicide in patients with depression and head injury. Moreover, when implementing suicide prevention systems in the society, age \<50 years, female sex, and the absence of other comorbidity could be thought of as high-risk factors associating with SA. When compared with a similar study in Finland \[[@B28-ijerph-16-03524]\], we considered that monthly income and urbanization level were controversial effects for the risk of SA in Taiwan. Our findings are valuable for clinicians and governments in developing Asian countries with a heritage similar to that of Taiwan.

However, this study had several limitations. First, this was a retrospective study that included all the NHI claims data on hospitalizations related to head injury and depression during the study period. The accuracy of NHI claims data is assured by the severe penalty incurred for fraud and false claiming. We identified suicide behaviors, head injury, and depression on the basis of the ICD-9-CM coding system. Patients with minor SA or SDO, head injury, or depression may not report to the medical care system, although the patients with mild head trauma have also been documented to be associated with depression and suicidality \[[@B29-ijerph-16-03524]\]. This might result in underestimation of the risks of SA and SDO. Second, because patients' identities were anonymized in the NHIRD, we could not directly understand the details of patients' disorders, for example, the Glasgow Coma Scale or the severity score during the admission for head injury, the site and number of brain injury, or whether the initial head injury was due to self-harm of a SA in this study. Patients with frontal lobe injury or multiple brain injuries would have more psychological deficits than those with a single parietal lobe injury. The other issue is that the details of personal psychosocial factors could not be accessed and analyzed, such as individual alienation from family and society, suicide ideation, severity of personal stress, severity of depression, and other frustrations with performance after the head injury. In addition, painkillers or other medications used for head injury and depression might lead to abuse and be involved in patients' suicidality. Those are potential confounders associated with the risks of suicide behaviors. Finally, although our study design already controlled for numerous confounding factors, to our knowledge, some unmeasured or unknown confounders may have remained. However, this large-scale, fairly unselective study has sufficiently evidenced to be hedged against the limitations and other confounding variables above. Patients with coexistence of depression and admission for head injury should be considered at a high risk for suicide attempt and drug overdose. They might need more concern and treatment by physicians for patient safety and suicide prevention.

5. Conclusions {#sec5-ijerph-16-03524}
==============

The risks of SA and SDO were proportionally increased by head injury in patients with depression in Taiwan. Our findings provide crucial information for clinicians and the government in Taiwan for implementing suicide prevention strategies. Moreover, whether it is adequate to offer long-term medical substances or tranquilizers to patients with depression admitted for head injury should be seriously questioned in the future. It is necessary to conduct more large-scale studies to clarify the effect of coexisting depression and head injury on suicidality worldwide.
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###### 

Distribution of age, sex, and comorbidities between the depression and comparison cohorts.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                          Total Depression\   Depression without Head Injury\   Depression with Head Injury\   Comparison Cohort\                                     
                                          *n* = 669,244       *n* = 647,375                     *n* = 21,869                   *n* = 1,338,487                                        
  --------------------------------------- ------------------- --------------------------------- ------------------------------ -------------------- --------- ------ --------- ------ ---------------
  Variable                                *n*                 \%                                *n*                            \%                   *n*       \%     *n*       \%     *p*-value ^a^

  Sex                                                                                                                                                                                 0.99

  Women                                   266,818             39.9                              256,988                        39.7                 9830      45.0   533,635   39.9   

  Men                                     402,426             60.1                              390,387                        60.3                 12,039    55.1   804,852   60.1   

  Age stratified                                                                                                                                                                      0.99

  ≤49                                     392,928             58.7                              382,001                        59.0                 10,927    50.0   785,856   58.7   

  50--64                                  135,145             20.2                              130,542                        20.2                 4603      21.1   270,290   20.2   

  ≥65                                     141,171             21.1                              134,832                        20.8                 6339      29.0   282,341   21.1   

  Age, mean ± SD ^§^                      46.8 ± 19.3         46.6 ± 19.3                       51.9 ± 19.0                    46.6 ± 19.3          \<0.001                           

  Monthly income ^†^                                                                                                                                                                  \<0.001

  \<15,000                                186,695             27.9                              179,296                        27.7                 7399      33.8   368,820   27.6   

  15,000--19,999                          350,534             52.4                              339,618                        52.5                 10,916    49.9   595,878   44.5   

  ≥20000                                  132,015             19.7                              128,461                        19.8                 3554      16.3   373,789   27.9   

  Urbanization level ^‡^                                                                                                                                                              \<0.001

  1 (highest)                             130,588             19.5                              126,385                        19.5                 4203      19.2   397,048   29.7   

  2                                       200,516             30.0                              193,631                        29.9                 6885      31.5   407,762   30.5   

  3                                       122,856             18.4                              119,185                        18.4                 3671      16.8   233,662   17.5   

  4 (lowest)                              215,284             32.2                              208,174                        32.2                 7110      32.5   300,015   22.4   

  Occupation category ^b^                                                                                                                                                             \<0.001

  Office worker                           293,059             43.8                              284,726                        44.0                 8333      38.1   722,439   54.0   

  Laborer                                 296,329             44.3                              286,725                        44.3                 9604      43.9   472,903   35.3   

  Other                                   79,856              11.9                              75,924                         11.7                 3932      18.0   143,145   10.7   

  Comorbidity                                                                                                                                                                         

  Schizophrenia                           4752                0.71                              3896                           0.60                 856       3.91   5091      0.38   \<0.001

  Alcohol-related illness                 20,923              3.13                              16,698                         2.58                 4225      19.3   4774      0.36   \<0.001

  Anxiety                                 5922                0.88                              4030                           0.62                 1892      8.65   3080      0.23   \<0.001

  Mental disorders                        32,178              4.81                              32,178                         4.97                 \-        \-     13,176    0.98   \<0.001

  Insomnia                                12,875              1.92                              9428                           1.46                 3447      15.8   7584      0.57   \<0.001

  Diabetes mellitus                       62,981              9.41                              58,629                         9.06                 4352      19.9   54,234    4.05   \<0.001

  Hypertension                            102,212             15.3                              94,411                         14.6                 7801      35.7   100,118   7.48   \<0.001

  Hyperlipidemia                          29,557              4.42                              26,260                         4.06                 3297      15.1   25,722    1.92   \<0.001

  Chronic obstructive pulmonary disease   36,755              5.49                              33,269                         5.14                 3486      15.9   33,050    2.47   \<0.001

  Coronary artery disease                 42,354              6.33                              38,133                         5.89                 4221      19.3   46,876    3.50   \<0.001

  Stroke                                  51,657              7.72                              46,567                         7.19                 5090      23.3   41,756    3.12   \<0.001

  Cirrhosis                               45,135              6.74                              40,106                         6.20                 5029      23.0   27,383    2.05   \<0.001
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Chi-square test; ^§^ *t*-test; ^a^ total depression vs. comparison cohort; ^†^ New Taiwan Dollar (NTD), 1 NTD is equal to 0.03 USD; ^‡^ the urbanization levels were divided according to the population density of the residential area into four levels: level one was the most urbanized and level four was the least urbanized; ^b^ the other occupation category included primarily retired, unemployed, and low-income populations.
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###### 

Incidences and risk factors associated with various factors for suicide attempt.

  ----------------------------------------------------------------------------------------------------------------------------
  Variable                                Event   PY           Rate ^\#^   Crude HR\                 Adjusted HR\
                                                                           (95% CI)                  (95% CI) ^\$^
  --------------------------------------- ------- ------------ ----------- ------------------------- -------------------------
  Depression                                                                                         

  None                                    796     6,850,494    1.16        1.00                      1.00

  Total depression                        1832    3,328,169    5.50        4.73 (4.36-5.14) \*\*\*   3.64 (3.34-3.97) \*\*\*

  Depression without head injury          1216    3,230,837    3.76        3.24 (2.96-3.54) \*\*\*   2.76 (2.52-3.02) \*\*\*

  Depression with head injury             616     97,331       63.3        53.9 (48.5-59.9) \*\*\*   37.4 (32.9-42.4) \*\*\*

  Age group, years                                                                                   

  ≤49                                     1746    6,385,103    2.73        1.36 (1.22-1.51) \*\*\*   1.45 (1.30-1.62) \*\*\*

  50--64                                  413     2,029,431    2.04        1.00                      1.00

  ≥65                                     469     1,764,128    2.66        1.28 (1.12-1.46) \*\*\*   1.10 (0.96-1.26)

  Sex                                                                                                

  Women                                   1007    4,063,886    2.48        1.00                      1.00

  Men                                     1621    6,114,777    2.65        1.07 (0.99-1.16)          

  Monthly income ^†^                                                                                 

  \<15,000                                813     2,661,854    3.05        2.28 (2.02-2.59) \*\*\*   1.66 (1.44-1.90) \*\*\*

  15,000-19,999                           1459    4,824,143    3.02        2.28 (2.03-2.56) \*\*\*   1.56 (1.38-1.76) \*\*\*

  ≥20,000                                 356     2,692,666    1.32        1.00                      1.00

  Urbanization level ^‡^                                                                             

  1 (highest)                             402     2,700,412    1.49        1.00                      1.00

  2                                       755     3,105,454    2.43        1.63 (1.45-1.84) \*\*\*   1.33 (1.18-1.50) \*\*\*

  3                                       511     1,800,161    2.84        1.91 (1.67-2.17) \*\*\*   1.51 (1.3-1.72) \*\*\*

  4 (lowest)                              960     2,572,636    3.73        2.50 (2.23-2.81) \*\*\*   1.64 (1.46-1.85) \*\*\*

  Occupation category ^b^                                                                            

  Office worker                           988     5,198,281    1.90        1.00                      1.00

  Laborer                                 1242    3,902,147    3.18        1.67 (1.54-1.82) \*\*\*   1.24 (1.13-1.36) \*\*\*

  Other                                   398     1,078,233    3.69        1.93 (1.72-2.17) \*\*\*   1.29 (1.13-1.47) \*\*\*

  Comorbidity                                                                                        

  Schizophrenia                                                                                      

  No                                      2546    10,131,823   2.51        1.00                      1.00

  Yes                                     82      46,839       17.5        6.91 (5.55-8.61) \*\*\*   3.28 (2.61-4.11) \*\*\*

  Alcohol-related illness                                                                            

  No                                      2361    10,070,372   2.34        1.00                      1.00

  Yes                                     267     108,291      24.7        10.3 (9.08-11.7) \*\*\*   3.80 (3.16-4.56) \*\*\*

  Anxiety                                                                                            

  No                                      2547    10,141,437   2.51        1.00                      1.00

  Yes                                     81      37,226       21.8        8.44 (6.76-10.5) \*\*\*   2.32 (1.82-2.96) \*\*\*

  Mental disorders                                                                                   

  No                                      2508    10,002,488   2.51        1.00                      1.00

  Yes                                     120     176,174      6.81        2.63 (2.19-3.16) \*\*\*   0.71 (0.58-0.87) \*\*

  Insomnia                                                                                           

  No                                      2480    10,099,868   2.46        1.00                      1.00

  Yes                                     148     78,794       18.8        7.39 (6.26-8.73) \*\*\*   2.37 (1.96-2.85) \*\*\*

  Diabetes mellitus                                                                                  

  No                                      2366    9,737,101    2.43        1.00                      1.00

  Yes                                     262     441,561      5.93        2.35 (2.07-2.67) \*\*\*   1.31 (1.13-1.51) \*\*\*

  Hypertension                                                                                       

  No                                      2255    9,417,225    2.39        1.00                      1.00

  Yes                                     373     761,437      4.90        1.97 (1.76-2.20) \*\*\*   1.13 (0.98-1.30)

  Hyperlipidemia                                                                                     

  No                                      2436    9,954,581    2.45        1.00                      1.00

  Yes                                     192     224,081      8.57        3.40 (2.94-3.94) \*\*\*   1.36 (1.15-1.60) \*\*\*

  Chronic obstructive pulmonary disease                                                              

  No                                      2457    9,921,558    2.48        1.00                      1.00

  Yes                                     171     257,104      6.65        2.58 (2.21-3.02) \*\*\*   1.22 (1.03-1.45) \*

  Coronary artery disease                                                                            

  No                                      2437    9,839,848    2.48        1.00                      1.00

  Yes                                     191     338,814      5.64        2.20 (1.90-2.55) \*\*\*   1.16 (0.97-1.38)

  Stroke                                                                                             

  No                                      2457    9,840,840    2.50        1.00                      1.00

  Yes                                     171     337,822      5.06        1.94 (1.66-2.27) \*\*\*   0.94 (0.79-1.13)

  Cirrhosis                                                                                          

  No                                      2301    9,878,155    2.33        1.00                      1.00

  Yes                                     327     300,507      10.9        4.57 (4.07-5.13) \*\*\*   1.26 (1.07-1.47) \*\*
  ----------------------------------------------------------------------------------------------------------------------------

CI, confidence interval; HR, hazard ratio; PY, person-years; ^\#^ incidence rate per 10,000 person-years; ^\$^ multivariable analysis included age, monthly income, urbanization level, and comorbidities of schizophrenia, alcohol-related illness, anxiety, mental disorders, insomnia, diabetes mellitus, hypertension, hyperlipidemia, chronic obstructive pulmonary disease, coronary artery disease, stroke, and cirrhosis; ^†^ New Taiwan Dollar (NTD), 1 NTD is equal to 0.03 USD; ^‡^ the urbanization levels were divided according to the population density of the residential area into four levels: level one was the most urbanized, and level four was the least urbanized; ^b^ the other occupation category included primarily retired, unemployed, and low-income populations; \* *p* \< 0.05, \*\* *p* \< 0.01, \*\*\* *p* \< 0.001.
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###### 

Comparison of hazard ratios for suicide attempt stratified by age, sex, and comorbidity between the depression and comparison cohorts.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                            Comparisonn\      Total Depression\   Depression without Head Injury\   Depression with Head Injury\                                                                                 
                            *n* = 1,338,487   *n* = 669,244       *n* = 647,375                     *n* = 21,869                                                                                                 
  ------------------------- ----------------- ------------------- --------------------------------- ------------------------------ ------------------------- ----- ------ ------------------------- ----- ------ --------------------------
  Age, years                                                                                                                                                                                                     

  ≤49                       434               1.02                1312                              6.14                           4.62 (4.13-5.17) \*\*\*   832   4.00   3.36 (2.98-3.78) \*\*\*   480   88.1   60.7 (52.1-70.6) \*\*\*

  50--64                    123               0.89                290                               4.43                           3.45 (2.76-4.30) \*\*\*   206   3.25   2.82 (2.24-3.55) \*\*\*   84    40.5   24.8 (17.7-34.7) \*\*\*

  ≥65                       239               1.95                230                               4.28                           1.81 (1.50-2.19) \*\*\*   178   3.45   1.54 (1.26-1.88) \*\*\*   52    23.5   8.09 (5.72-11.4) \*\*\*

  *p* for interaction                                                                                                              \<0.001                                \<0.001                                

  Sex                                                                                                                                                                                                            

  Female                    267               0.98                740                               5.51                           4.57 (3.95-5.27) \*\*\*   420   3.24   2.98 (2.55-3.49) \*\*\*   320   69.4   60.1 (49.9-72.3) \*\*\*

  Male                      529               1.28                1092                              5.50                           3.15 (2.82-3.51) \*\*\*   796   4.12   2.62 (2.34-2.93) \*\*\*   296   57.8   25.0 (20.9-30.0) \*\*\*

  *p* for interaction                                                                                                              0.003                                  \<0.001                                

  Monthly income ^†^                                                                                                                                                                                             

  \<15,000                  267               1.49                546                               6.26                           3.41 (2.92-3.97) \*\*\*   372   4.42   2.65 (2.2-3.12) \*\*\*    174   55.6   26.6 (21.1-33.5) \*\*\*

  15,000--19,999            414               1.36                1045                              5.88                           3.43 (3.05-3.86) \*\*\*   702   4.06   2.62 (2.32-2.97) \*\*\*   343   68.9   36.3 (30.6-43.0) \*\*\*

  ≥20,000                   115               0.57                241                               3.56                           4.55 (3.61-5.74) \*\*\*   142   2.15   3.14 (2.44-4.04) \*\*\*   99    61.1   78.2 (56.5-108.3) \*\*\*

  *p* for interaction                                                                                                              0.004                                  \<0.001                                

  Urbanization level ^‡^                                                                                                                                                                                         

  1 (highest)               150               0.73                252                               3.88                           4.03 (3.27-4.98) \*\*\*   146   2.31   2.70 (2.13-3.41) \*\*\*   106   56.9   52.0 (2.13-3.41) \*\*\*

  2                         220               1.05                535                               5.32                           4.01 (3.41-4.72) \*\*\*   329   3.37   2.85 (2.40-3.39) \*\*\*   206   66.5   46.7 (37.3-58.5) \*\*\*

  3                         166               1.40                345                               5.59                           3.29 (2.72-3.98) \*\*\*   246   4.10   2.65 (2.16-3.23) \*\*\*   99    58.8   28.2 (21.0-38.1) \*\*\*

  4 (lowest)                260               1.71                700                               6.63                           3.23 (2.79-3.74) \*\*\*   495   4.83   2.60 (2.24-3.03) \*\*     205   66.4   28.8 (23.1-35.8) \*\*\*

  *p* for interaction                                                                                                              0.001                                  \<0.001                                

  Occupation category ^b^                                                                                                                                                                                        

  Office worker             314               0.84                674                               4.56                           4.13 (3.59-4.74) \*\*\*   442   3.07   3.11 (2.68-3.61) \*\*\*   232   61.2   49.4 (40.2-60.7) \*\*\*

  Laborer                   353               1.45                889                               6.03                           3.36 (2.96-3.81) \*\*\*   602   4.21   2.57 (2.25-2.94) \*\*\*   287   66.7   34.3 (28.5-41.2) \*\*\*

  Other                     129               1.84                269                               7.14                           2.97 (2.39-3.71) \*\*\*   172   4.77   2.21 (1.75-2.80) \*\*\*   97    59.2   22.6 (16.5-31.1) \*\*\*

  *p* for interaction                                                                                                              0.002                                  \<0.001                                

  Comorbidity                                                                                                                                                                                                    

  None                      581               0.95                997                               4.06                           3.80 (3.43-4.22) \*\*\*   774   3.19   2.99 (2.68-3.34) \*\*\*   223   74.3   68.0 (58.2-79.4) \*\*\*

  With any one              215               2.96                835                               9.60                           2.57 (2.20-2.99) \*\*\*   442   5.51   1.53 (1.30-1.81) \*\*\*   393   58.4   14.8 (12.4-17.5) \*\*\*

  *p* for interaction                                                                                                              0.003                                  0.05                                   
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

CI, confidence interval; HR, hazard ratio; PY, person-years; ^\#^ incidence rate per 10,000 person-years; ^\$^ multivariable analysis included age, monthly income, urbanization level, and comorbidities of schizophrenia, alcohol-related illness, anxiety, mental disorders, insomnia, diabetes mellitus, hypertension, hyperlipidemia, chronic obstructive pulmonary disease, coronary artery disease, stroke, and cirrhosis; ^†^ New Taiwan Dollar (NTD), 1 NTD is equal to 0.03 USD; ^‡^ the urbanization levels were divided according to the population density of the residential area into four levels: level one was the most urbanized, and level four was the least urbanized; ^b^ the other occupation category included primarily retired, unemployed, and low-income populations; ^§^ individuals with schizophrenia, depression, alcohol-related illness, anxiety, mental disorders, and insomnia were classified into the comorbidity group; \*\* *p* \< 0.01, \*\*\* *p* \< 0.001.
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###### 

Comparison of incidences and hazard ratios for suicide attempt stratified by age, sex, and comorbidities between patients with depression with and without head injury.

  ------------------------------------------------------------------------------------------
                            Depression without Head Injury\   Depression with Head Injury\
                            *n* = 647,375                     *n* = 21,869
  ------------------------- --------------------------------- ------------------------------
  All                       1.00                              14.8 (13.2-16.7) \*\*\*

  Age, years                                                  

  ≤49                       1.00                              18.8 (16.4-21.5) \*\*\*

  50--64                    1.00                              9.62 (7.07-13.1) \*\*\*

  ≥65                       1.00                              6.00 (4.21-8.57) \*\*\*

  *p* for interaction                                         \<0.001

  Sex                                                         

  Female                    1.00                              21.7 (18.4-25.7) \*\*\*

  Male                      1.00                              10.6 (8.92-12.5) \*\*\*

  *p* for interaction                                         \<0.001

  Monthly income ^†^                                          

  \<15000                   1.00                              11.3 (9.08-14.0) \*\*\*

  15000--19999              1.00                              14.9 (12.7-17.4) \*\*\*

  ≥20000                    1.00                              26.1 (19.2-35.6) \*\*\*

  *p* for interaction                                         \<0.001

  Urbanization level ^‡^                                      

  1 (highest)               1.00                              22.0 (16.3-29.7) \*\*\*

  2                         1.00                              17.5 (14.2-21.5) \*\*\*

  3                         1.00                              12.5 (9.45-16.5) \*\*\*

  4 (lowest)                1.00                              11.8 (9.70-14.5) \*\*\*

  *p* for interaction                                         \<0.001

  Occupation category ^b^                                     

  Office worker             1.00                              17.8 (14.7-21.6) \*\*\*

  Laborer                   1.00                              14.2 (12.0-16.8) \*\*\*

  Other                     1.00                              12.0 (8.27-15.2) \*\*\*

  *p* for interaction                                         \<0.001

  Comorbidity ^§^                                             

  None                      1.00                              22.7 (19.6- 26.4) \*\*\*

  With any one              1.00                              9.54 (8.32-10.9) \*\*\*

  *p* for interaction                                         \<0.001
  ------------------------------------------------------------------------------------------

CI, confidence interval; HR, hazard ratio; ^\$^ multivariable analysis included age, monthly income, urbanization level, and comorbidities of schizophrenia, alcohol-related illness, anxiety, mental disorders, insomnia, diabetes mellitus, hypertension, hyperlipidemia, chronic obstructive pulmonary disease, coronary artery disease, stroke, and cirrhosis; ^†^ New Taiwan Dollar (NTD), 1 NTD is equal to 0.03 USD; ^‡^ the urbanization levels were divided according to the population density of the residential area into four levels: level one was the most urbanized areas, and level four was the least urbanized areas; ^b^ the other occupation category included primarily retired, unemployed, and low-income populations; ^§^ individuals with schizophrenia, depression, alcohol-related illness, anxiety, mental disorders, and insomnia were classified into the comorbidity group; \*\* *p* \< 0.01, \*\*\* *p* \< 0.001.
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###### 

Incidences and hazard ratios of suicidal drug overdose (per 10,000 person-years) in patients with depression with or without head injury using the Cox method.

                              Comparison Cohort   Total Depression          Depression without Head Injury   Depression with Head Injury
  --------------------------- ------------------- ------------------------- -------------------------------- -----------------------------
  Person-years                                                                                               
  Event, *n*                  1810                3104                      2251                             853
  Rate                        2.64                9.34                      6.97                             88.6
  Crude HR (95% CI)           1 (Reference)       3.53 (3.33-3.74) \*\*\*   2.64 (2.48-2.80) \*\*\*          33.1 (30.5-35.9) \*\*\*
  Adjusted HR ^\$^ (95% CI)   1 (Reference)       2.71 (2.55-2.88) \*\*\*   2.20 (2.06-2.34) \*\*\*          17.1 (15.5-18.8) \*\*\*
  Crude HR (95% CI)                                                         1 (Reference)                    12.5 (11.6-13.5) \*\*\*
  Adjusted HR ^\$^ (95% CI)                                                 1 (Reference)                    9.04 (8.22-9.94) \*\*\*

^\$^ Multivariable analysis included age, monthly income, urbanization level, and comorbidities of schizophrenia, alcohol-related illness, anxiety, mental disorders, insomnia, diabetes mellitus, hypertension, hyperlipidemia, chronic obstructive pulmonary disease, coronary artery disease, stroke, and cirrhosis; \*\*\* *p* \< 0.001.
